Ned Milenkovich, PharmD, JD
This article is not intended as legal advice and should not be used as such. When legal questions arise, pharmacists should consult with attorneys familiar with the relevant drug and pharmacy laws. Ned Milenkovich is chair of the Healthcare Law practice at Much Shelist PC and vice chair of the Illinois State Board of Pharmacy. Contact him at: 312-521-2482 / [email protected]
Telepharmacy opportunities: New horizons in patient care
Telepharmacy is still a novelty, and there is a lag in implementation of new laws after professional and technological innovations are deployed.
340B program: Opportunities for community pharmacy involvement
Many pharmacies are aware of the 340B Drug Pricing Program, but few understand the mechanics of how such a program works and to what extent a community pharmacy may be able to capitalize on its benefits.
FDA argues legal definition of compounding after deaths of 21 polo ponies
A pharmacy that engages in veterinary compounding has been embroiled in a struggle with FDA since it compounded a vitamin supplement for administration to 21 polo ponies during the U.S. Open Polo Championships in April 2009. When they were injected with the compounded vitamin supplement, all 21 ponies collapsed and died. FDA's subsequent court challenge raises the question of when compounding becomes manufacture.
Lab-developed tests: FDA oversight unclear
Pharmacies soon may be stocking their shelves with laboratory-developed tests that first require FDA approval.
Bar-code technology can enhance patient safety
Use of bar-code technology is widespread in the general retail environment. Its advantages have not yet been fully exploited in the hospital and community-pharmacy settings.
Controlled substances, LTC nurses, and verbal drug orders
The relationship between prescribing practitioners and nurses working in a long-term-care (LTC) facility is of significant concern to the LTC facility when controlled substances are needed.
Healthcare reform and pharmacies
An overview of several provisions of "The Patient Protection and Affordable Care Act" affecting pharmacies and pharmacy practice.
Medical marijuana movement forges ahead
While the government deems that marijuana has a "high potential for abuse" and "has no currently accepted medical use," some states have undertaken initiatives to pass legislation permitting its use for pain control and for control of nausea and vomiting by cancer patients.
A financial checkup for pharmacies
Pharmacies are experiencing financial, regulatory and reimbursement challenges that have increased pressure on their operations. A regular review of financial circumstances and business options can help pharmacies stay afloat in turbulent times.
HITECH Act calls for new HIPAA notice requirements
The American Recovery and Reinvestment Act, signed into law on February 17, included the Health Information Technology for Economic and Clinical Health Act (HITECH), which expands covered-entity and business-associate requirements established by the Health Insurance Portability and Accountability Act of 1996 (HIPAA).